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produces. These include enterotoxins and colonization fac-
tors apart from other antigens like the lipopolysaccharide
(LPS), which are part of the ‘O’ antigen. Over 100 types
of ‘O’ groups have been detected in ETEC strains in com-
bination with different ﬂagellar (H) antigens, that together
make the serotype (O:H) of the bacteria. Although exten-
sive efforts have been made to determine the prevalence of
the toxins and colonization factors in ETEC strains isolated
in different regions of the world, relatively little is known
about the serotype of the bacteria circulating in different
countries, especially those that are prevalent at this time.
Recent epidemiological studies have shown that ETEC
strains from different regions differ in their phenotypic char-
acteristics. These ﬁndings are important to determine which
vaccines would be suitable for use in one region but not in
another as a measure of protection against ETEC infections.
ETEC isolated from two geographically different locations,
Mexico and Bangladesh, have been characterized for their
‘O’ and ‘H’ antigens as well as for their enterotoxin types
and colonization factor production. Overall a variety of
ETEC phenotypes were found to be present in both set-
tings. Twelve serotypes were common in both settings. A few
serogroups were only present in isolates from Bangladesh
(O20, O115, O126, O128, O114), while others were present
only in strains isolated in Mexico (O103, O170, O22). The pre-
dominant colonization factors in both settings were CFA/I,
CS5+CS6, CS6 as well as CS1+CS2/CS3. Colonization factors
were produced by strains belonging to a few ‘O’ serogroups,
CFA/I (O126 and O128), CS5+CS6 (O115 and O167), CS6
(O169), CS1+CS2/CS3 (O6). Based on these results, formu-
lation of an effective multivalent ETEC vaccine will have to
include not only the major colonization factors and LT tox-
oid but also the LPS of important serogroups. An inactivated
killed ETEC vaccine that has undergone extensive testing
includes strains of serogroups O6, O25, O78 and O167. Based
on the present data this vaccine would in addition need the
incorporation of strains belonging to serogroups O115 and
O126 to be more effective in the protection against the most
common cause of bacterial diarrhea in early childhood and
the second most predominant cause of diarrhea in adults
in endemic countries, including tourists travelling to these
areas.
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Despite the availability of two internationally licensed,
newer generation typhoid vaccines that are safe and effec-
tive and despite an annual global typhoid mortality burden
estimated at over 200,000 deaths, typhoid vaccines are not
routinely used as public health interventions in develop-
ing countries with high typhoid burdens. Although there are
multiple reasons for the failure to introduce these vaccines
into public health programs for the poor, a gap in evi-
dence to inform vaccine policy is a major factor. To address
this gap in evidence, the International Vaccine Institute,
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ith the support of the Bill and Melinda Gates Foundation,
as coordinated a multi-country, multidisciplinary program
f research, called the Diseases of the Most Impoverished
DOMI) Program, to inform policy about typhoid vaccine
ntroduction in Asia. This research program, which has been
ndertaken in Bangladesh, China, India, Indonesia, Pakistan,
nd Vietnam, has demonstrated the burden of typhoid fever
o be high, but geographically heterogeneous. The research
as also demonstrated a high ﬁnancial cost associated with
yphoid fever, and a modest cost of purchasing and deliv-
ring one of the two currently available, internationally
icensed typhoid vaccines (Vi polysaccharide). Demonstra-
ion projects with Vi vaccine have shown that the vaccine is
easibly delivered in mass immunization campaigns in both
chool and community settings, and when delivered in these
ampaigns the vaccine confers both direct and herd protec-
ion. As well, there is a high population demand for a vaccine
ith the cost and characteristics of Vi polysaccharide, and
ven a willingness on the part of developing country popu-
ations to pay for this vaccine, particularly for vaccination
f children. In aggregate, these ﬁndings have helped to
otivate a recently published, strengthened WHO recom-
endation for routine typhoid vaccination in settings with
igh typhoid disease burdens.
oi:10.1016/j.ijid.2008.05.052
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remarkable event in recent years has been the emergence
f strains of Vibrio cholerae O1 that possess traits of both
he classical and El Tor biotypes. These strains were ﬁrst
ncountered from sporadic cases of cholera isolated from
992 onwards in Matlab, Bangladesh. Phenotypic and geno-
ypic traits failed to categorize these strains into classical
r El Tor biotype and were designated as the Matlab vari-
nts. The Matlab variants assumed greater signiﬁcance when
trains of V. cholerae O1 isolated from Beira, Mozambique
n 2005 displayed typical traits of the El Tor biotype but car-
ied the classical CTX prophage. A more recent analysis of
. cholerae O1 strains isolated in Bangladesh during the past
our and a half decades revealed that from 2001 onwards
ll strains associated with cholera belonged to the El Tor
iotype but produced classical cholera toxin (CT) which was
ifferent from the prototype El Tor biotype that produced
l Tor CT. This new variant of the El Tor biotype is now
ominant in several other countries. At this time, it is not
ertain whether the change in CT subtype in the El Tor strains
ill enhance their epidemic potential. Given that there are
ifferences between the classical and El Tor biotypes, the
election of the El Tor biotype which produces classical CT
ould seem to indicate an evolutionary optimization of the
l Tor biotype and represents a new more efﬁcient emerging
orm of the El Tor biotype. Under the cholera surveillance
rogram of the International Centre for Diarrheal Disease
esearch in Bangladesh, an increasing trend in the number
